Gufic BioSciences Faces Technical Shift Amid Declining Profits and Rising Interest Expenses
Gufic BioSciences has experienced a recent evaluation adjustment, indicating a shift in its technical outlook. Key metrics suggest potential challenges, with a decline in profits over the past year. Despite this, institutional investor participation has slightly increased, reflecting ongoing interest in the company's long-term potential.
Gufic BioSciences, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in evaluation, reflecting a shift in its technical outlook. The stock's technical indicators have transitioned from a sideways trend to a bearish stance, suggesting a change in market sentiment. Key metrics such as the Moving Average Convergence Divergence (MACD) and the Know Sure Thing (KST) are currently positioned in a bearish range, indicating potential challenges ahead. The company's operating profit to interest ratio has reached a low point, while its interest expenses have seen notable growth. Additionally, Gufic BioSciences has reported a decline in profits over the past year, despite a positive return on the stock.
On the institutional front, there has been a slight increase in participation, with institutional investors raising their stake in the company. This could reflect a strategic interest in the company's long-term potential, despite the current technical challenges.
Overall, Gufic BioSciences is navigating a complex landscape characterized by both operational hurdles and evolving investor dynamics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
